Beneficial Effect of Upadacitinib in an Adult Patient with Juvenile Idiopathic Arthritis-associated Uveitis after Unsatisfactory Response to Tofacitinib: A Case Report.
Karoline WalscheidCarsten HeinzThomas RathMartin ScheelArnd HeiligenhausPublished in: Ocular immunology and inflammation (2022)
This case suggests that switching JAK-I might be a successful strategy in the treatment of JIAU, despite previously incomplete response to other preparations.